Cano Health, Inc.
CANOQ
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -21.05% | 5.24% | 18.50% | 11.22% | 23.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.05% | 5.24% | 18.50% | 11.22% | 23.08% |
| Cost of Revenue | -11.57% | 19.10% | 39.58% | 39.13% | 30.23% |
| Gross Profit | -102.70% | -69.01% | -86.02% | -162.51% | -16.43% |
| SG&A Expenses | -7.63% | -25.34% | -27.69% | -6.37% | -0.12% |
| Depreciation & Amortization | -32.51% | -5.90% | 5.51% | 37.38% | 43.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.78% | 11.39% | 27.44% | 40.98% | 26.45% |
| Operating Income | -227.67% | -164.96% | -260.45% | -711.31% | -333.26% |
| Income Before Tax | -689.25% | 8.17% | -334.26% | -1,881.95% | -6,188.94% |
| Income Tax Expenses | -- | -86.68% | 88.38% | -331.40% | -- |
| Earnings from Continuing Operations | -689.31% | 8.57% | -338.97% | -1,759.00% | -71,176.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 92.69% | -27.72% | 300.13% | 1,308.21% | 4,253.69% |
| Net Income | -1,376.75% | -11.23% | -380.36% | -2,539.28% | -4,365.15% |
| EBIT | -227.67% | -164.96% | -260.45% | -711.31% | -333.26% |
| EBITDA | -1,347.94% | -5,637.58% | -38,489.94% | -1,952.53% | -155.98% |
| EPS Basic | -670.62% | 11.15% | -293.59% | -1,918.58% | -3,504.52% |
| Normalized Basic EPS | -7,177.57% | -78.37% | 1,494.10% | -3,631.59% | -129.44% |
| EPS Diluted | -657.04% | -7.84% | -293.59% | -1,571.40% | -66,021.98% |
| Normalized Diluted EPS | -13,274.82% | -78.37% | 1,494.10% | -4,250.63% | -134.30% |
| Average Basic Shares Outstanding | 91.63% | 25.19% | 22.05% | 30.75% | 25.28% |
| Average Diluted Shares Outstanding | 4.26% | 25.19% | 22.05% | 11.22% | 7.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
